GnRH agonist vs. hCG for triggering of ovulation--differential effects on gene expression in human granulosa cells

PLoS One. 2014 Mar 6;9(3):e90359. doi: 10.1371/journal.pone.0090359. eCollection 2014.

Abstract

Objective: To investigate the mRNA expression of genes related to steroidogenesis and OHSS in granulosa cells (GCs) of patients triggered with GnRH agonist compared to patients triggered with hCG.

Design: Mural GCs were obtained at the time of oocyte retrieval and gene expression was analyzed using quantitative real time RT-PCR.

Settings: Single center, case control study.

Patient(s): 24 women who were treated with GnRH agonist or hCG for triggering of ovulation.

Interventions: GC collection.

Main outcome measure(s): The expression of genes related to steroidogenesis and OHSS in mural GCs.

Results: The fertilization rate was similar in the two groups. The mRNA expression of CYP19A1 (0.50 vs 1, arbitrary unit), CYP11A1 (0.6 vs. 1) and 3 beta hydroxysteroid-dehydrogenase (0.39 vs 1) was significantly lower in the GnRH group. The expression of VEGF (0.74 vs. 1) and inhibin β B (0.38 vs 1) was lower in the GnRH analog triggered group.

Conclusion: Expression of genes related to steroidogenesis is lower at the time of oocyte retrieval in patients triggered with GnRH agonist. The decreased expression of VEGF and inhibin β B in the GnRH agonist group can explain the mechanism of early OHSS prevention.

MeSH terms

  • 3-Hydroxysteroid Dehydrogenases / genetics
  • Adult
  • Aromatase / genetics
  • Case-Control Studies
  • Cholesterol Side-Chain Cleavage Enzyme / genetics
  • Chorionic Gonadotropin / pharmacology
  • Female
  • Fertilization in Vitro / methods
  • Gene Expression / drug effects
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / metabolism
  • Granulosa Cells / drug effects*
  • Granulosa Cells / metabolism
  • Humans
  • Inhibins / genetics
  • Oocyte Retrieval / methods
  • Ovarian Hyperstimulation Syndrome / genetics
  • Ovarian Hyperstimulation Syndrome / metabolism
  • Ovulation / drug effects*
  • Ovulation Induction / methods
  • Phosphoproteins / genetics
  • Receptors, LH / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Triptorelin Pamoate / pharmacology*
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • Chorionic Gonadotropin
  • Phosphoproteins
  • Receptors, LH
  • Vascular Endothelial Growth Factor A
  • steroidogenic acute regulatory protein
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Inhibins
  • 3-Hydroxysteroid Dehydrogenases
  • Aromatase
  • CYP19A1 protein, human
  • Cholesterol Side-Chain Cleavage Enzyme

Grants and funding

The authors have no support or funding to report.